NIPT（AssuriT-A）

Introduction

Pregnancy can be exciting for families, and also bring concerns about medical decisions or the challenges of parenting. Prenatal screening offers genetic insights early in pregnancy about the health for the pregnant person and their growing baby.

AssuriT-A is a blood-based genetic, prenatal screening test for the pregnant person that screens for common chromosomal conditions that affect a baby's health. AssuriT-A uses targeted-sequencing technology to deliver highly accurate results and unique insights for both singleton and twin pregnancies. It uses a simple blood test from mom to check the baby’s risk for chromosomal abnormalities, such as Down syndrome.

Technology

Products based on Proprietary Targeted Sequencing Technology, Provide Most Accurate and Cost-Effective NIPT

• Targeted thousands of loci within disease related regions（including loci that maternal and fetal have different genotypes）

• Targeted loci have more than 200x coverage for deep analysis and better accuracy

• With focused analysis, total cost is reduced by several folds

Can NlPT replace Amniocentesis and CVS？

While the NIPT is reasonably accurate with a low false positiverate, abnormal results need to be confirmed by amniocentesis or chorionic villus sampling.

AssuriT-A is a screening test, which means that this test does not make a final diagnosis. A high risk result means that your pregnancy has a higher chance of having a specific genetic condition. However, you cannot be sure whether your baby has that condition based on the screening result alone. All medical decisions should be made after discussion with your healthcare provider regarding diagnostic testing during the pregnancy, like chorionic villus sampling (CVS) or amniocentesis, or testing the baby after birth.

How is NIPT done？